+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of statin adverse effects with supplemental Coenzyme Q10 and statin drug discontinuation



Treatment of statin adverse effects with supplemental Coenzyme Q10 and statin drug discontinuation



Biofactors 25(1-4): 147-152



Fifty consecutive new cardiology clinic patients who were on statin drug therapy (for an average of 28 months) on their initial visit were evaluated for possible adverse statin effects (myalgia, fatigue, dyspnea, memory loss, and peripheral neuropathy). All patients discontinued statin therapy due to side effects and began supplemental CoQ(10) at an average of 240 mg/day upon initial visit. Patients have been followed for an average of 22 months with 84% of the patients followed now for more than 12 months. The prevalence of patient symptoms on initial visit and on most recent follow-up demonstrated a decrease in fatigue from 84% to 16%, myalgia from 64% to 6%, dyspnea from 58% to 12%, memory loss from 8% to 4% and peripheral neuropathy from 10% to 2%. There were two deaths from lung cancer and one death from aortic stenosis with no strokes or myocardial infarctions. Measurements of heart function either improved or remained stable in the majority of patients. We conclude that statin-related side effects, including statin cardiomyopathy, are far more common than previously published and are reversible with the combination of statin discontinuation and supplemental CoQ(10). We saw no adverse consequences from statin discontinuation.

(PDF emailed within 1 workday: $29.90)

Accession: 050847805

Download citation: RISBibTeXText

PMID: 16873939


Related references

Patient characteristics and statin discontinuation-related factors during treatment of hypercholesterolemia: an observational non-interventional study in patients with statin discontinuation (STAY study). Turk Kardiyoloji Dernegi Arsivi 44(1): 53-64, 2016

The STatin Adverse Treatment Experience Survey: Experience of patients reporting side effects of statin therapy. Journal of Clinical Lipidology 2019, 2019

Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event. American Journal of Cardiology 114(6): 826-831, 2014

Comparative efficacy and adverse effects of the addition of ezetimibe to statin versus statin titration in chronic kidney disease patients. Therapeutic Advances in Cardiovascular Disease 7(6): 306-315, 2014

Predictors of Statin Adherence, Switching, and Discontinuation in the USAGE Survey Understanding Statin Use in America and Gaps in Patient Education. Journal of Clinical Lipidology 7(3): 245-246, 2013

Chinese red rice depletes muscle coenzyme Q10 and maintains muscle damage after discontinuation of statin treatment. Journal of the American Geriatrics Society 54(4): 718-720, 2006

Tu-W27:4 Comparative lipid effects of combination therapy with a statin and extended-release niacin versus statin plus ezetimibe versus a statin alone. Atherosclerosis Suppl.s 7(3): 174-175, 2006

A peri-operative statin update for non-cardiac surgery. Part I: The effects of statin therapy on atherosclerotic disease and lessons learnt from statin therapy in medical (non-surgical) patients. Anaesthesia 63(1): 52-64, 2007

Adverse Events of Statin-Fenofibrate Therapy versus Statin Alone A Meta-analysis of Randomized Controlled Trials. 2013

Adverse events following statin-fenofibrate therapy versus statin alone: a meta-analysis of randomized controlled trials. Clinical and Experimental Pharmacology and Physiology 40(3): 219-226, 2013

Adverse events of statin-fenofibric acid versus statin monotherapy: a meta-analysis of randomized controlled trials. Current Medical Research and Opinion 29(3): 181-188, 2013

The effects of statin treatment on adrenal and sexual function and nitric oxide levels in hypercholesterolemic male patients treated with a statin. Journal of Clinical Lipidology 10(6): 1452-1461, 2017

Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system?. Expert Opinion on Drug Safety 17(5): 457-465, 2018

A comparative meta-analysis of the efficacy of statin-ezetimibe co-therapy versus statin monotherapy in reducing cardiovascular and cerebrovascular adverse events in patients with type 2 diabetes mellitus. European Review for Medical and Pharmacological Sciences 23(5): 2302-2310, 2019

Alternative drug therapy of severe hypercholesterolemia: fibrate-statin combination or increased dose of statin?. Atherosclerosis 109(1-2): 256, 1994